400 related articles for article (PubMed ID: 34830221)
21. Dendritic cell gene therapy.
Onaitis M; Kalady MF; Pruitt S; Tyler DS
Surg Oncol Clin N Am; 2002 Jul; 11(3):645-60. PubMed ID: 12487060
[TBL] [Abstract][Full Text] [Related]
22. Cancer immunotherapy via dendritic cells.
Palucka K; Banchereau J
Nat Rev Cancer; 2012 Mar; 12(4):265-77. PubMed ID: 22437871
[TBL] [Abstract][Full Text] [Related]
23. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
Xia D; Moyana T; Xiang J
Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
[TBL] [Abstract][Full Text] [Related]
24. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
H Yi D; Appel S
Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
[TBL] [Abstract][Full Text] [Related]
25. The use of dendritic cells in cancer immunotherapy.
Schuler G; Schuler-Thurner B; Steinman RM
Curr Opin Immunol; 2003 Apr; 15(2):138-47. PubMed ID: 12633662
[TBL] [Abstract][Full Text] [Related]
26. Cancer vaccines based on dendritic cells loaded with tumor-associated antigens.
Burdin N; Moingeon P
Cell Biol Toxicol; 2001; 17(2):67-75. PubMed ID: 11499697
[TBL] [Abstract][Full Text] [Related]
27. Effect of dendritic cell-based immunotherapy on hepatocellular carcinoma: A systematic review and meta-analysis.
Chen C; Ma YH; Zhang YT; Zhang F; Zhou N; Wang X; Liu T; Li YM
Cytotherapy; 2018 Aug; 20(8):975-989. PubMed ID: 30072299
[TBL] [Abstract][Full Text] [Related]
28. How much help does a vaccine-induced T-cell response need?
Weber JS; Mulé JJ
J Clin Invest; 2001 Mar; 107(5):553-4. PubMed ID: 11238555
[No Abstract] [Full Text] [Related]
29. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
[TBL] [Abstract][Full Text] [Related]
30. Gastrointestinal cancer stem cells as targets for innovative immunotherapy.
Chivu-Economescu M; Necula LG; Matei L; Dragu DL; Neagu AI; Alexiu I; Bleotu C; Diaconu CC
World J Gastroenterol; 2020 Apr; 26(14):1580-1593. PubMed ID: 32327907
[TBL] [Abstract][Full Text] [Related]
31. Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade.
Hübbe ML; Jæhger DE; Andresen TL; Andersen MH
Front Immunol; 2020; 11():578349. PubMed ID: 33101304
[TBL] [Abstract][Full Text] [Related]
32. DCs in lymphoma--biology and therapeutic aspects.
Schultze JL; Fiore F; von Bergwelt-Baildon M
Cytotherapy; 2004; 6(2):138-47. PubMed ID: 15203990
[No Abstract] [Full Text] [Related]
33. Targeting dendritic cells with antigen-containing liposomes: antitumour immunity.
Altin JG; van Broekhoven CL; Parish CR
Expert Opin Biol Ther; 2004 Nov; 4(11):1735-47. PubMed ID: 15500402
[TBL] [Abstract][Full Text] [Related]
34. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
Bodey B; Siegel SE; Kaiser HE
In Vivo; 2004; 18(1):81-100. PubMed ID: 15011756
[TBL] [Abstract][Full Text] [Related]
35. Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy.
Nguyen-Pham TN; Yang DH; Nguyen TA; Lim MS; Hong CY; Kim MH; Lee HJ; Lee YK; Cho D; Bae SY; Ahn JS; Kim YK; Chung IJ; Kim HJ; Lee JJ
Cell Mol Immunol; 2012 Jan; 9(1):45-53. PubMed ID: 21822297
[TBL] [Abstract][Full Text] [Related]
36. DC therapy for metastatic melanoma.
Ingram SB; O'Rourke MG
Cytotherapy; 2004; 6(2):148-53. PubMed ID: 15203991
[No Abstract] [Full Text] [Related]
37. Tumor lysate-loaded Bacterial Ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer vaccines.
Dobrovolskienė N; Pašukonienė V; Darinskas A; Kraśko JA; Žilionytė K; Mlynska A; Gudlevičienė Ž; Mišeikytė-Kaubrienė E; Schijns V; Lubitz W; Kudela P; Strioga M
Vaccine; 2018 Jul; 36(29):4171-4180. PubMed ID: 29895501
[TBL] [Abstract][Full Text] [Related]
38. Recent developments in cancer vaccines.
Palucka K; Ueno H; Banchereau J
J Immunol; 2011 Feb; 186(3):1325-31. PubMed ID: 21248270
[TBL] [Abstract][Full Text] [Related]
39. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
Cancel JC; Crozat K; Dalod M; Mattiuz R
Front Immunol; 2019; 10():9. PubMed ID: 30809220
[TBL] [Abstract][Full Text] [Related]
40. Dendritic Cells and Their Role in Immunotherapy.
Gardner A; de Mingo Pulido Á; Ruffell B
Front Immunol; 2020; 11():924. PubMed ID: 32508825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
